| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.4M | +4.9% | +18.8% |
| Cost of Revenue | $5.2M | -13.9% | +21.9% |
| R&D Expense | $294K | +97.9% | +17.8% |
| SG&A Expense | $3.5M | -7.5% | +27.2% |
| Operating Income | -$2.4M | +29.2% | +25.4% |
| Pre-tax Income | -$9.5M | -339.4% | -267.0% |
| Income Tax | -$24K | -318.2% | -160.6% |
| Net Income | -$9.1M | -334.0% | -263.4% |
| EPS (Basic) | -$0.12 | -300.0% | -200.0% |
| EPS (Diluted) | -$0.12 | -300.0% | -200.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.1M | +3.4% | -11.5% |
| Accounts Receivable | $3.7M | +40.2% | +29.3% |
| Inventory | $177K | -17.4% | +54.3% |
| Current Assets | $34.2M | +0.1% | +31.4% |
| Total Assets | $44.9M | +8.0% | +40.2% |
| Current Liabilities | $63.2M | +3.1% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.5M | — | — |
| Investing Cash Flow | -$713K | — | — |
| Financing Cash Flow | $16.0M | — | — |
| +3.0% |
| Long-term Debt | $4.8M | +3178.5% | +4039.4% |
| Total Liabilities | $69.0M | +10.5% | +10.4% |
| Stockholders' Equity | -$26.6M | +5.1% | +11.1% |